US Broker Ratings

Ardent Health, Inc. (ARDT) Stock Analysis: A 35% Potential Upside Amid Strong Revenue Growth

Ardent Health, Inc. (NASDAQ: ARDT) is making waves in the healthcare sector with its impressive revenue growth and a promising potential upside, garnering the attention of investors seeking robust opportunities..

Addus HomeCare Corporation (ADUS) Stock Analysis: 26% Potential Upside Makes It a Healthcare Stock to Watch

Addus HomeCare Corporation (NASDAQ: ADUS) stands out in the healthcare sector with a compelling growth narrative and a potential upside that might catch the eye of any discerning investor. With..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: Impressive Potential Upside of 133.73% Amid Robust Revenue Growth

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a trailblazer in the biotechnology sector, has been creating ripples in the stock market with its promising pipeline and substantial growth metrics. Based in Durham,..

Crinetics Pharmaceuticals, Inc. (CRNX) Investor Outlook: Exploring a Promising 80.66% Upside

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), a San Diego-based biotechnology company, is making waves in the healthcare sector with its cutting-edge research and development in novel therapeutics for rare endocrine diseases..

Arrowhead Pharmaceuticals, Inc. (ARWR) Stock Analysis: Unpacking a 27.65% Potential Upside in Biotech Innovation

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) represents a compelling opportunity for investors seeking exposure to the innovative sector of biotechnology. With a market capitalization of $5.01 billion, Arrowhead is a prominent..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: Unveiling a 37.61% Upside Potential in the Biotech Arena

Xenon Pharmaceuticals Inc. (XENE) is making waves in the biotechnology sector with its significant focus on neuroscience, aiming to address neurological and psychiatric disorders. Headquartered in Burnaby, Canada, Xenon is..

Mirum Pharmaceuticals (MIRM) Stock Analysis: Robust Revenue Growth and Strong Buy Ratings Capture Investor Attention

Mirum Pharmaceuticals, Inc. (MIRM), a pioneer in the biotechnology sector, has been making waves with its innovative approach to tackling rare and orphan diseases. With a focus on developing and..

Envista Holdings Corporation (NVST) Stock Analysis: Unveiling a 11.43% Potential Upside for Investors

Envista Holdings Corporation (NYSE: NVST), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, is gaining attention from investors due to its strategic positioning..

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: Exploring a 68% Upside Potential

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) has been capturing the attention of investors with its promising outlook in the biotechnology sector. The company, headquartered in Coral Gables, Florida, is dedicated to..

Metsera, Inc. (MTSR) Stock Analysis: Discover the 4.78% Upside Potential in the Biotechnology Sector

Metsera, Inc. (NASDAQ: MTSR) is making waves in the biotechnology sector with its innovative approach to combating obesity and related diseases. As a clinical-stage company based in New York, Metsera..

Apogee Therapeutics, Inc. (APGE) Investor Outlook: Exploring the 72.52% Potential Upside

Apogee Therapeutics, Inc. (NASDAQ: APGE), a burgeoning name in the biotechnology sector, presents an intriguing opportunity for investors keen on the healthcare industry. With a current market capitalization of $3.65..

Haemonetics Corporation (HAE) Stock Analysis: A Closer Look at Growth Potential Amid Market Volatility

Haemonetics Corporation (NYSE: HAE), a prominent player in the healthcare sector specializing in medical devices, has recently caught the attention of investors. With a market capitalization of $2.42 billion, this..

Perrigo Company plc (PRGO) Stock Analysis: Exploring a 61% Potential Upside Amid Solid Dividend Yield

Perrigo Company plc (PRGO) stands at a pivotal intersection for investors seeking opportunities in the healthcare sector, specifically within the niche of specialty and generic drug manufacturing. With its current..

ACADIA Pharmaceuticals (ACAD): Investor Outlook on Potential 43.78% Upside

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a prominent player in the biotechnology sector, is garnering significant investor attention owing to its focus on developing treatments for central nervous system (CNS) disorders..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: A Look at Its 49% Revenue Growth and Potential Upside

Alignment Healthcare, Inc. (NASDAQ: ALHC) presents an intriguing investment opportunity within the healthcare sector, particularly in the specialized industry of healthcare plans. This Orange, California-based company operates a consumer-centric platform..

Arcellx, Inc. (ACLX) Stock Analysis: A Promising Biotech Play with Significant Upside Potential

For investors with a keen interest in the biotechnology sector, Arcellx, Inc. (NASDAQ: ACLX) presents an intriguing opportunity. As a healthcare company specializing in innovative immunotherapies, Arcellx is making strides..

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Exploring a 20% Upside Potential in Biotech

Akero Therapeutics, Inc. (NASDAQ: AKRO), a promising player in the biotechnology sector, is making waves with its innovative approach to treating serious metabolic diseases. Headquartered in South San Francisco, California,..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Exploring a 36.85% Potential Upside in Innovative RNA Therapeutics

Avidity Biosciences, Inc. (NASDAQ: RNA) is making waves in the biotechnology sector with its innovative approach to RNA therapeutics. Based in San Diego, California, Avidity is focused on delivering antibody..

Axsome Therapeutics (AXSM) Stock Analysis: Unpacking a Potential 45% Upside in Biotech

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is capturing the attention of investors seeking opportunities in the dynamic biotechnology sector. With a robust pipeline of therapies targeting central nervous system (CNS) disorders,..

Elanco Animal Health (ELAN) Stock Analysis: Growth Potential and Market Dynamics

Elanco Animal Health Incorporated (NYSE: ELAN) stands at the crossroads of innovation and animal welfare. With a market capitalization of $9.82 billion, this healthcare sector player is making strides in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds